ABSTRACT
Purpose: Setup errors are inherent in the process of daily radiation therapy (RT) delivery. Pelvic RT for rectal cancer is one of the body sites associated with the largest shift among other body sites. This study aimed to evaluate interfraction random and systematic errors and hence propose the optimum planning target volume (PTV) in patients with rectal cancer. Methods and Materials: Translational and angular isocenter displacements were retrospectively collected for 189 patients. Random and systematic errors were determined, and then the PTV margin was computed. Effect of positioning, body mass index (BMI), and type of immobilization were studied. Portal images before and after online correction were used to define PTV for no-daily image-guided radiotherapy (IGRT) and daily IGRT respectively. Results: Before the online correction, the systematic errors were 2.5, 2.8, and 3.0 mm for superior-inferior (SI), right-left (RL), and anterior-posterior (AP) directions, respectively, compared with 2.1, 1.7, and 1.8 mm after online correction. The random errors were 6.2, 7.4, and 8.2 mm in SI, RL, and AP, respectively, before online correction, compared with 4, 4.2, and 4.5 mm after online correction. The recommended PTV margin was 0.7 and 1.0 cm for daily IGRT and no-daily IGRT, respectively. The prone position and BMI >30 kg/m2 warrant higher margins in no-daily IGRT cases, 1.2 and 1.4 cm, respectively. Conclusions: The prone position, BMI >30 kg/m2, and belly board device are associated with larger daily setup errors warranting higher PTV margins for no-daily IGRT; however, that can be avoided by using daily IGRT.
ABSTRACT
Background and Purpose: Stereotactic Radiosurgery (SRS) is a specialized radiotherapy treatment technique for Arteriovenous Malformations (AVM) in which Computed Tomography (CT) images are used for dose calculations. The purpose of this study was to investigate CT image distortions caused by embolic agents and quantify the influence of these distortions on dose calculations. Methods: Eight AVM patients administered embolic agents prior to SRS were included. Original plans were compared to new recalculated plans using two sets of images. The first set was created by masking the embolic material and artefacts, the second was the diagnostic CT images. In addition, treatment plans were created for an anthropomorphic phantom with water inserts, then with known volumes of embolic materials to study the dosimetric effect of each material. Results: Relative to patients' original plans, maximum Monitor Unit (MU) difference was -4.4% with whole brain masking, -1.3% with artefact masking, -4.1% with embolic masking, and -4.5% with artefact-free diagnostic images. Calculated dose differences were within ± 3.5% for all plans. In phantom, Gamma pass rate was 96% for both embolic agents with conformal fields and 99.9% with dynamic arcs. Dose and MU differences in phantom plans were negligible. Conclusion: Relative dose differences between the original plans and the corrected ones were not clinically remarkable. We recommend evaluating the effect of embolic materials on individual patients' plans. The whole brain corrected planning CT images or diagnostic CT images could be utilized to calculate the magnitude of dose reduction caused by embolic materials and correct it if necessary.
